C12N 2770/12033
Use of viral protein as therapeutic agent other than vaccine
Official title: Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory
C12N2770/12033 (Use of viral protein as therapeutic agent other than vaccine) appears on 11 US grants and 23 published applications in this corpus.
Search patents in C12N- Granted patents
- 11
- Published applications
- 23
- Assignees
- 6
- Inventors
- 4
- Latest grant
- 13 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 0 |
| 2015 | 0 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 0 |
| 2018 | 2 | 1 |
| 2019 | 1 | 3 |
| 2020 | 1 | 1 |
| 2021 | 2 | 3 |
| 2022 | 0 | 1 |
| 2023 | 1 | 2 |
| 2024 | 0 | 2 |
| 2025 | 1 | 1 |
| 2026 | 0 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Synthetic peptide compounds and methods of use13 May 2025US 12,297,235 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use14 Nov 2023US 11,814,414 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use16 Mar 2021US 10,947,279 B2Realta Holdings, LLC
- Synthetic peptide compounds and methods of use2 Mar 2021US 10,933,116 B2Realta Holdings, LLC
- Peptide compounds to regulate the complement system24 Nov 2020US 10,844,093 B2Realta Holdings, LLC
- Peptide compounds to regulate the complement system24 Sep 2026US 2026/0285907 A1Realta Holdings, LLC
- Synthetic peptide compounds and methods of use14 May 2026US 2026/0132170 A1Realta Holdings, LLC
- Peptide compounds to regulate the complement system29 Jan 2026US 2026/0028373 A1Realta Holdings, LLC
- Peptide compounds to regulate the complement system24 Apr 2025US 2025/0129124 A1Realtaholdings,LLC
- Peptide compounds to regulate the complement system19 Sep 2024US 2024/0309047 A1Realta Holdings, LLC
Most cited
By later US patents
- Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof14US 8,241,843 B2Eastern Virginia Medical School · 2012
- Peptide compounds to regulate the complement system9US 8,906,845 B2Eastern Virginia Medical School · 2014
- Derivative peptide compounds and methods of use8US 10,005,818 B2Realta Holdings, LLC · 2018
- Peptide compounds to regulate the complement system4US 10,414,799 B2Realta Holdings, LLC · 2019
- Peptide compounds to regulate the complement system4US 10,844,093 B2Realta Holdings, LLC · 2020